Shihchen Kuo
Overview
Explore the profile of Shihchen Kuo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
2955
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chong K, Yang C, Chang Y, Kuo S, Chen J, Lee C, et al.
Surg Obes Relat Dis
. 2025 Feb;
PMID: 39915185
Background: Existing studies are mainly focused on overall obesity or specific subpopulations, while the disease burden among patients with different characteristics of obesity progression remains uncertain. Objectives: To conduct a...
2.
Herman W, Kuo S, Zhang P
Diabetes Obes Metab
. 2024 Dec;
27(3):1626-1627.
PMID: 39691985
No abstract available.
3.
Kuo S, Ye W, Wang D, McEwen L, Villatoro Santos C, Herman W
Diabetes Care
. 2024 Nov;
PMID: 39565893
Objective: We evaluated the real-world cost-effectiveness of the National Diabetes Prevention Program (NDPP) for people with prediabetes in a large workforce with employer-sponsored health insurance. Research Design And Methods: We...
4.
5.
Chang K, Kuo F, Yang C, Yang C, Ou H, Kuo S
Cardiovasc Diabetol
. 2024 Oct;
23(1):367.
PMID: 39420429
Background: Non-alcoholic fatty liver diseases (NAFLDs)/non-alcoholic steatohepatitis (NASH) are the most common liver disorders among patients with type 2 diabetes. Newer classes of glucose-lowering agents (GLAs), such as glucagon-like peptide-1...
6.
Su H, Nguyen T, Lin W, Ou H, Kuo S
Cardiovasc Diabetol
. 2024 Oct;
23(1):357.
PMID: 39385193
Background: Most existing risk equations for predicting/stratifying individual diabetic kidney disease (DKD) risks were developed using relatively dated data from selective and homogeneous trial populations comprising predominately Caucasian type 2...
7.
Chong K, Chang Y, Yang C, Chou C, Ou H, Kuo S
Cardiovasc Diabetol
. 2024 Jul;
23(1):246.
PMID: 38987782
Background: This study quantifies the longitudinal economic burden for a wide spectrum of incident complications, metabolic syndrome (MS)-related risk factors, and comorbidities in patients with MS. Methods: This retrospective study...
8.
Yang C, Chong K, Wang C, Ou H, Kuo S
Cardiovasc Diabetol
. 2024 Jul;
23(1):244.
PMID: 38987773
Objective: To adapt risk prediction equations for myocardial infarction (MI), stroke, and heart failure (HF) among patients with type 2 diabetes in real-world settings using cross-institutional electronic health records (EHRs)...
9.
Gonzalez J, Bebu I, Krause-Steinrauf H, Hoogendoorn C, Crespo-Ramos G, Presley C, et al.
Diabetes Care
. 2024 Feb;
47(4):610-619.
PMID: 38416773
Objective: We evaluated whether adding basal insulin to metformin in adults with early type 2 diabetes mellitus (T2DM) would increase emotional distress relative to other treatments. Research Design And Methods:...
10.
Cherrington A, Tripputi M, Younes N, Herman W, Katona A, Groessl E, et al.
Diabetes Care
. 2024 Jan;
47(4):603-609.
PMID: 38190625
Objective: Diabetes is associated with reduced health-related quality of life (HRQoL). Information on the relationship between HRQoL and glucose-lowering medications in recently diagnosed type 2 diabetes (T2D) is limited. We...